Compounded tirzepatide tablets the rarest format
Do not inject MOUNJARO in the same injection site used for other medicines
Promptly addressing any adverse reactions ensures a smoother weight loss journey
Compliance with the FDAs cGMP standards is another key differentiator between traditional 503A compounding pharmacies and 503B outsourcing facilities
It comes in three pre-filled, single-use, subcutaneous doses: 0.5 mg, 1 mg, and 2 mg for weekly administration
Finally, SELECTs unambiguous message that weight management saves lives makes a compelling case, and creates an ethical imperative, for payers and policy makers to expand coverage, including revisiting the statutes prohibiting Medicare from covering anti-obesity drugs